Travere Therapeutics's total assets for Q1 2025 were $548.80M, a decrease of -7.63% from the previous quarter. TVTX total liabilities were $515.98M for the fiscal quarter, a -3.56% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.